Mike Matson
Stock Analyst at Needham
(2.21)
# 1,488
Out of 4,412 analysts
323
Total ratings
41.5%
Success rate
-6.18%
Average return
Main Sectors:
31 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $224 → $236 | $183.42 | +28.67% | 7 | Apr 26, 2024 | |
| CNMD CONMED | Maintains: Buy | $129 → $107 | $61.90 | +72.86% | 16 | Apr 25, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $71 → $82 | $73.26 | +11.93% | 18 | Apr 24, 2024 | |
| OCX OncoCyte | Maintains: Buy | $3.6 → $4.25 | $2.44 | +74.18% | 11 | Apr 24, 2024 | |
| STE STERIS | Reiterates: Hold | n/a | $201.54 | - | 7 | Apr 12, 2024 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $0.67 | +273.08% | 13 | Apr 12, 2024 | |
| PSNL Personalis | Reiterates: Buy | $3.5 | $1.25 | +180.00% | 12 | Apr 11, 2024 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $88 | $73.38 | +19.92% | 14 | Apr 11, 2024 | |
| SRDX Surmodics | Reiterates: Buy | $47 | $26.17 | +79.59% | 14 | Apr 10, 2024 | |
| KIDS OrthoPediatrics | Reiterates: Buy | $37 | $29.94 | +23.58% | 13 | Apr 10, 2024 | |
| ENOV Enovis | Reiterates: Buy | $82 | $55.10 | +48.82% | 8 | Apr 10, 2024 | |
| ATRC AtriCure | Reiterates: Buy | $46 | $22.61 | +103.45% | 20 | Apr 10, 2024 | |
| HOLX Hologic | Reiterates: Buy | $90 | $75.71 | +18.87% | 8 | Apr 10, 2024 | |
| INGN Inogen | Reiterates: Hold | n/a | $6.48 | - | 9 | Apr 9, 2024 | |
| INMD InMode | Reiterates: Hold | n/a | $17.02 | - | 11 | Apr 9, 2024 | |
| AORT Artivion | Maintains: Buy | $25 | $20.27 | +23.33% | 10 | Apr 8, 2024 | |
| SWAV ShockWave Medical | Downgrades: Hold | n/a | $328.99 | - | 7 | Apr 5, 2024 | |
| FNA Paragon 28 | Reiterates: Buy | $18 | $8.97 | +100.67% | 11 | Apr 4, 2024 | |
| LIVN LivaNova | Reiterates: Buy | $72 | $55.10 | +30.67% | 16 | Mar 20, 2024 | |
| NARI Inari Medical | Reiterates: Buy | $72 | $38.07 | +89.13% | 3 | Mar 6, 2024 | |
| VCYT Veracyte | Maintains: Buy | $30 → $33 | $19.48 | +69.40% | 10 | Feb 23, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $21 → $24 | $13.85 | +73.29% | 16 | Feb 21, 2024 | |
| AXNX Axonics | Downgrades: Hold | n/a | $66.54 | - | 16 | Jan 17, 2024 | |
| MASI Masimo | Downgrades: Hold | n/a | $135.24 | - | 13 | Jan 3, 2024 | |
| TFX Teleflex | Downgrades: Hold | n/a | $206.71 | - | 5 | Jun 21, 2023 | |
| PEN Penumbra | Downgrades: Hold | n/a | $205.50 | - | 5 | Mar 29, 2023 | |
| MDT Medtronic | Downgrades: Hold | n/a | $79.25 | - | 7 | May 27, 2022 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Hold | n/a | $119.75 | - | 15 | May 27, 2022 | |
| HAE Haemonetics | Downgrades: Hold | n/a | $87.66 | - | 6 | Jan 27, 2022 | |
| SIBN SI-BONE | Maintains: Buy | n/a | $14.27 | - | 1 | Mar 9, 2021 | |
| GMED Globus Medical | Maintains: Buy | n/a | $50.37 | - | 1 | Feb 18, 2021 |
ResMed
Apr 26, 2024
Maintains: Buy
Price Target: $224 → $236
Current: $183.42
Upside: +28.67%
CONMED
Apr 25, 2024
Maintains: Buy
Price Target: $129 → $107
Current: $61.90
Upside: +72.86%
Boston Scientific
Apr 24, 2024
Maintains: Buy
Price Target: $71 → $82
Current: $73.26
Upside: +11.93%
OncoCyte
Apr 24, 2024
Maintains: Buy
Price Target: $3.6 → $4.25
Current: $2.44
Upside: +74.18%
STERIS
Apr 12, 2024
Reiterates: Hold
Price Target: n/a
Current: $201.54
Upside: -
Lucid Diagnostics
Apr 12, 2024
Reiterates: Buy
Price Target: $2.5
Current: $0.67
Upside: +273.08%
Personalis
Apr 11, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.25
Upside: +180.00%
Merit Medical Systems
Apr 11, 2024
Reiterates: Buy
Price Target: $88
Current: $73.38
Upside: +19.92%
Surmodics
Apr 10, 2024
Reiterates: Buy
Price Target: $47
Current: $26.17
Upside: +79.59%
OrthoPediatrics
Apr 10, 2024
Reiterates: Buy
Price Target: $37
Current: $29.94
Upside: +23.58%
Enovis
Apr 10, 2024
Reiterates: Buy
Price Target: $82
Current: $55.10
Upside: +48.82%
AtriCure
Apr 10, 2024
Reiterates: Buy
Price Target: $46
Current: $22.61
Upside: +103.45%
Hologic
Apr 10, 2024
Reiterates: Buy
Price Target: $90
Current: $75.71
Upside: +18.87%
Inogen
Apr 9, 2024
Reiterates: Hold
Price Target: n/a
Current: $6.48
Upside: -
InMode
Apr 9, 2024
Reiterates: Hold
Price Target: n/a
Current: $17.02
Upside: -
Artivion
Apr 8, 2024
Maintains: Buy
Price Target: $25
Current: $20.27
Upside: +23.33%
ShockWave Medical
Apr 5, 2024
Downgrades: Hold
Price Target: n/a
Current: $328.99
Upside: -
Paragon 28
Apr 4, 2024
Reiterates: Buy
Price Target: $18
Current: $8.97
Upside: +100.67%
LivaNova
Mar 20, 2024
Reiterates: Buy
Price Target: $72
Current: $55.10
Upside: +30.67%
Inari Medical
Mar 6, 2024
Reiterates: Buy
Price Target: $72
Current: $38.07
Upside: +89.13%
Veracyte
Feb 23, 2024
Maintains: Buy
Price Target: $30 → $33
Current: $19.48
Upside: +69.40%
NeoGenomics
Feb 21, 2024
Maintains: Buy
Price Target: $21 → $24
Current: $13.85
Upside: +73.29%
Axonics
Jan 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $66.54
Upside: -
Masimo
Jan 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $135.24
Upside: -
Teleflex
Jun 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $206.71
Upside: -
Penumbra
Mar 29, 2023
Downgrades: Hold
Price Target: n/a
Current: $205.50
Upside: -
Medtronic
May 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $79.25
Upside: -
Zimmer Biomet Holdings
May 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $119.75
Upside: -
Haemonetics
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $87.66
Upside: -
SI-BONE
Mar 9, 2021
Maintains: Buy
Price Target: n/a
Current: $14.27
Upside: -
Globus Medical
Feb 18, 2021
Maintains: Buy
Price Target: n/a
Current: $50.37
Upside: -